Related Experiment Video
Updated: May 20, 2026
06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis
Ocular Immunology and Inflammation
|July 25, 2012
Summary
Systemic steroid prophylaxis before cataract surgery in patients with posterior uveitis may accelerate visual recovery. This approach showed a faster return to best visual acuity post-operation, potentially improving outcomes for these complex cases.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Cataract surgery in patients with posterior uveitis presents challenges due to high risks of postoperative complications like cystoid macular edema.
- Standardized preoperative and perioperative systemic steroid prophylaxis was implemented to mitigate these risks.
Purpose of the Study:
- To evaluate the impact of systemic steroid prophylaxis on visual recovery after cataract extraction in patients with posterior uveitis.
Main Methods:
- Retrospective analysis of 30 cataract extraction procedures in 24 patients with posterior uveitis.
- Procedures were divided into two groups: 19 before and 11 after the introduction of steroid prophylaxis.
- Visual recovery was assessed by Snellen acuity at six months, improvement in lines of acuity, and time to achieve best postoperative acuity.
Main Results:
- The prophylaxis group showed a trend towards better median visual acuity at six months (20/30 vs. 20/80) and a significantly faster median time to achieve best visual acuity (1.8 vs. 5.9 months).
- Faster visual recovery in the prophylaxis group was independent of intraocular lens implantation or specific postoperative complications.
- Pseudophakic eyes in the prophylaxis group also demonstrated significantly better median acuity at six months.
Conclusions:
- Preoperative systemic steroid prophylaxis appears to hasten postoperative visual recovery in patients undergoing cataract surgery for posterior uveitis.
- This prophylactic regimen may offer benefits independent of intraocular lens implantation, suggesting a direct effect on inflammation control and visual rehabilitation.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...